Tandem Diabetes Care Reports First Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Tandem Diabetes (TNDM) Misses Q1 EPS by 4c, Affirms Guidance
April 30, 2015 4:55 PM EDTTandem Diabetes (NASDAQ: TNDM) reported Q1 EPS of ($0.83), $0.04 worse than the analyst estimate of ($0.79). Revenue for the quarter came in at $12.3 million versus the consensus estimate of $12.19 million. Tandem Diabetes reaffirmed FY2015 guidance.
For the year ending December 31, 2015, the Company affirms its... More
